DIABIL-2
Ultra-low dose of IL-2 for the treatment of recently diagnosed type 1 diabetes
| Coordinator | University of Basel ; Assistance Publique -Hopitaux De Paris ; DEUTSCHES KREBSFORSCHUNGSZENTRUM HEIDELBERG ; INSERM TRANSFERT SA ; ACADEMISCH ZIEKENHUIS LEIDEN ; THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE ; Iltoo Pharma (France) |
| Grant period | 2012-10-01 - 2019-03-31 |
| Funding body | European Union |
| Call number | FP7-HEALTH-2012-INNOVATION-1 |
| Grant number | 305380 |
| Identifier | G:(EU-Grant)305380 |